You can buy or sell SUPN and other stocks, options, ETFs, and crypto commission-free!
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. Its neurology portfolio consists of Oxtellar XR and Trokendi XR, which treats patients with epilepsy. Read More The firm also develops product candidates for the treatment of impulsive aggression and for the treatment of attention deficit hyperactivity disorder. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.
52 Week High
52 Week Low
The Motley FoolMay 8
3 Top Value Stocks to Buy in May
Did anyone say sell in May and go away? I wouldn't do that. In fact, I'd consider any drop in stocks now an opportunity, especially if the growth stories of underlying companies are still intact. Even now, there's plenty of value hidden in some stocks that you could consider dipping your fingers into. Our Motley Fool contributors believe Supernus Pharmaceuticals (NASDAQ:SUPN), Iron Mountain (NYSE:IRM), and Party City (NYSE:PRTY) are three value stocks ripe for buying now. Here's why. A prove-it story Geo...
The Motley FoolMay 8
Supernus Pharmaceuticals Inc (SUPN) Q1 2019 Earnings Call Transcript
Supernus Pharmaceuticals Inc (NASDAQ:SUPN) Q1 2019 Earnings Call , 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good morning, ladies and gentlemen, and welcome to the Supernus Pharmaceuticals' First Quarter 2019 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, this conference call is be...
Seeking AlphaMay 8
Supernus Pharmaceuticals (SUPN) CEO, Jack Khattar on Q1 2019 Results - Earnings Call Transcript
Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) Q1 2019 Earnings Conference Call May 8, 2019 9:00 AM ET Company Participants Jack Khattar - President, Chief Executive Officer Greg Patrick - Chief Financial Officer Peter Vozzo - Investor Relations Conference Call Participants Ken Cacciatore - Cowen & Co. David Steinberg - Jefferies Nick Rubino - Stifel Patrick Trucchio - Berenberg Capital Mick Ingerman - Piper Jaffray Esther Hong - Janney Operator Good morning ladies and gentlemen and welcome to the...
$0.47 per share
$0.34 per share